Treatment of Urge Urinary Incontinence in Women After Failure of Cesa or Vasa
Surgical Treatment of Urge IncontinenceUrge urinary incontinence can be a disorder caused by destroyed pelvic structures. We repaired the uteri-sacral ligaments (USL) by cesa or vasa. The study evaluates if solifenacin can lead to continence after surgery or if also the pubo-urethral ligaments (PUL) need to be repaired.
EFFECTIVENESS OF THE NEUROADAPTATIVE FOR URGE INCONTINENCE
Urge IncontinenceIn this clinical trials the sponsor want to assess a self-controlled-energo-neuroadaptative-regulation in patient with urge incontinence
Reduction of Bladder Injection Pain With Belladonna Opiate Suppository
Overactive BladderUrinary Urge Incontinence3 moreThe purpose of this study is to test whether using belladonna & opiate suppositories (B&Os) can improve patient discomfort during Onabotulinumtoxin A (BoNT) injection into the bladder for treatment of overactive bladder, neurogenic detrusor overactivity, or interstitial cystitis.
Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women
Urge Urinary IncontinenceThe purpose of this study is to determine if pelvic surgery can improve urge urinary incontinence in women more than standard medical treatment.
Do Patient Anxiety Levels Decrease Urodynamic Test Reproducibility?
AnxietyOveractive Bladder5 moreThis study will look at how pre-test anxiety levels affect the reproducibility of symptoms during routine urodynamic testing in women. Urodynamics is a test that assesses the function of the lower urinary tract, including the bladder.
Central Nervous System Changes Following BotulinumtoxinA Injection in the Bladder
Multiple SclerosisLower Urinary Tract Symptoms4 moreThe purpose of this prospective research study is to evaluate higher neural changes following intradetrusor injection of Botulinum toxin-A (BTX-A) in patients with Multiple Sclerosis (MS). Concurrent Urodynamic and Functional Magnetic Resonance (fMRI) data will be recorded pre- and post- intravesical injection of BTX-A in patients with Multiple Sclerosis (MS) and neurogenic detrusor activity (NDO). Other objectives are to evaluate the role of urinary biomarkers such as brain-derived neurotropic factor (BDNF) and nerve growth factor (NGF) associated with bladder overactivity and, to determine whether the common validated urgency questionnaires correlate with fMRI findings and urinary biomarker concentration pre- and post- BTX-A injection in patients with MS and NDO.
Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive...
Overactive BladderDementia3 moreWomen presenting with overactive bladder symptoms will be randomized to one of 3 arms (anticholinergic, beta-3 agonist, placebo). They will undergo baseline cognitive testing, functional MRI of the brain. Cognitive testing and functional MRI will be repeated after taking their double blinded intervention for 30 days.
Time to be Ready to Void: a New Tool to Assess the Time Needed to Perform Micturition in Multiple...
Gait DisordersNeurologic3 moreThe aim of the study is to create a specific test to assess the global time required to go to the toilet and to perform micturition, at the moment the patient decides to urinate in multiple sclerosis population, and to assess its reliability.
Urgent-SQ in Treatment of Overactive Bladder Syndrome: 9-yr Follow up
Overactive BladderUrinary Frequency or Urgency Adverse Event2 moreLong term open label study on safety and durability of the Urgent-SQ tibial implant device for refractory overactive bladder syndrome (OAB).
SMAD2, SMAD3 AND TGF-β GENE EXPRESSION IN URGE URINARY INCONTINENCE
SMAD2SMAD33 moreUrge urinary incontinence (UUI) is a common health problem. Changes in collagen metabolism in pelvic support organs, such as uterosacral ligaments (USLs), might be responsible for the complex pathophysiology of UUI. The TGF-β pathway is involved in collagen synthesis and degradation. The Transforming Growth Family- β (TGF-β) superfamily has essential intracellular signaling components, such as newly identified SMAD family members. We evaluated the changes in the levels of TGF-β and SMAD gene and protein expression in the USL of patients with concomitant pelvic organ prolapse (POP) and UUI.